Login Register Cart 0
Recent Advances in Inflammation & Allergy Drug Discovery

Recent Advances in Inflammation & Allergy Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-2708
ISSN (Online): 2772-2716

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Integrating Precision Medicine in Diabetes Mellitus: Enhancing Wound Healing and Shaping Future Therapies

Author(s): Abhash Kumar, Avijit Mazumder*orcid of author, Priyanka Bansalorcid of author, Pankaj Kumar Tyagiorcid of author and Amrinder Kaurauthors OrcID

Volume 19, Issue 3, 2025

Published on: 03 October, 2024

Page: [343 - 358] Pages: 16

DOI: 10.2174/0127722708335238240920035556

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

This extensive analysis explores the dynamic interface between precision medicine and diabetes mellitus treatment, with a specific emphasis on wound healing in diabetic populations. Beginning with an insightful introduction, the article underscores the critical importance of effective wound healing within the broader context of diabetes mellitus, while tracing the evolutionary trajectory of precision medicine in healthcare. By elucidating the pathophysiological intricacies of diabetic wound healing, the review unveils the complex molecular mechanisms that drive this multifaceted process. Subsequently, a meticulous exploration follows into the application of precision medicine paradigms in diabetic wound care, delineating fundamental principles and diverse avenues through which precision medicine strategies can optimize diabetes management. Through a nuanced discussion of targeted therapies and interventions, the review highlights burgeoning approaches tailored to individual patient needs, accentuating the transformative potential of precision medicine in reshaping treatment paradigms. Drawing upon clinical trials and compelling case studies, the article offers valuable insights into the real-world efficacy of precision treatment modalities, elucidating successful applications and their profound implications for diabetic wound healing outcomes. Moreover, the review anticipates and addresses emerging challenges and future trajectories within the field, including the pivotal roles of biomarkers and diagnostic modalities, the integration of telemedicine platforms, and the increasing influence of artificial intelligence on diabetic wound healing endeavours. By synthesizing contemporary knowledge and delineating prospective pathways, this review underscores the catalytic potential of precision medicine in heralding a new era of enhanced outcomes for diabetic patients grappling with impaired wound healing.

Keywords: Artificial intelligence, biomarkers, diabetes mellitus, precision medicine, wound healing, targeted therapy.

« Previous Next »

Graphical Abstract

Graphical abstract illustrating key findings of the study

[1]
Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol 2022; 18(9): 525-39.
[http://dx.doi.org/10.1038/s41574-022-00690-7] [PMID: 35668219]
[2]
Kumar R, Saha P, Kumar Y, Sahana S, Dubey A, Prakash O. A Review on Diabetes Mellitus: Type 1 & Type 2. World J Pharm Pharm Sci 2020; 9(10): 838-50.
[3]
Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes Mellitus: Insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology 2021; 2(2): 36-50.
[http://dx.doi.org/10.3390/diabetology2020004]
[4]
Reinehr T. Type 2 diabetes mellitus in children and adolescents. World J Diabetes 2013; 4(6): 270-81.
[http://dx.doi.org/10.4239/wjd.v4.i6.270] [PMID: 24379917]
[5]
Ceriello A, Testa R. Antioxidant anti-inflammatory treatment in type 2 diabetes. Diabetes Care 2009; 32 (Suppl 2)(Suppl. 2): S232-6.
[http://dx.doi.org/10.2337/dc09-S316] [PMID: 19875557]
[6]
Lemelman MB, Letourneau L, Greeley SAW. Neonatal diabetes mellitus. Clin Perinatol 2018; 45(1): 41-59.
[http://dx.doi.org/10.1016/j.clp.2017.10.006] [PMID: 29406006]
[7]
Chang M, Nguyen TT. Strategy for Treatment of Infected Diabetic Foot Ulcers. Acc Chem Res 2021; 54(5): 1080-93.
[http://dx.doi.org/10.1021/acs.accounts.0c00864] [PMID: 33596041]
[8]
Gong H, Ren Y, Li Z, et al. Clinical characteristics and risk factors of lower extremity amputation in the diabetic inpatients with foot ulcers. Front Endocrinol (Lausanne) 2023; 14: 1144806.
[9]
Glover K, Stratakos AC, Varadi A, Lamprou DA. 3D scaffolds in the treatment of diabetic foot ulcers: New trends vs conventional approaches. Int J Pharm 2021; 599: 120423.
[http://dx.doi.org/10.1016/j.ijpharm.2021.120423] [PMID: 33647412]
[10]
Kolimi P, Narala S, Nyavanandi D, Youssef AAA, Dudhipala N. Innovative treatment strategies to accelerate wound healing: Trajectory and recent advancements. Cells 2022; 11(15): 2439.
[http://dx.doi.org/10.3390/cells11152439] [PMID: 35954282]
[11]
Dasari N, Jiang A, Skochdopole A, et al. Updates in diabetic wound healing, inflammation, and scarring. Semin Plast Surg 2021; 35(3): 153-8.
[http://dx.doi.org/10.1055/s-0041-1731460] [PMID: 34526862]
[12]
Čoma M, Manning JC, Kaltner H, Gál P. The sweet side of wound healing: Galectins as promising therapeutic targets in hemostasis, inflammation, proliferation, and maturation/remodeling. Expert Opin Ther Targets 2023; 27(1): 41-53.
[http://dx.doi.org/10.1080/14728222.2023.2175318] [PMID: 36716023]
[13]
Spampinato SF, Caruso GI, De Pasquale R, Sortino MA, Merlo S. The treatment of impaired wound healing in diabetes: Looking among old drugs. Pharmaceuticals (Basel) 2020; 13(4): 60.
[http://dx.doi.org/10.3390/ph13040060] [PMID: 32244718]
[14]
Willenborg S, Injarabian L, Eming SA. Role of Macrophages in Wound Healing. Cold Spring Harb Perspect Biol 2022; 14(12): a041216.
[http://dx.doi.org/10.1101/cshperspect.a041216] [PMID: 36041784]
[15]
Zhang S, Ge G, Qin Y, et al. Recent advances in responsive hydrogels for diabetic wound healing. Mater Today Bio 2023; 18: 100508.
[http://dx.doi.org/10.1016/j.mtbio.2022.100508] [PMID: 36504542]
[16]
Al-Mansoori L, Al-Jaber H, Prince MS, Elrayess MA. Role of inflammatory cytokines, growth factors and adipokines in adipogenesis and insulin resistance. Inflammation 2022; 45(1): 31-44.
[http://dx.doi.org/10.1007/s10753-021-01559-z] [PMID: 34536157]
[17]
Mallik SB, Jayashree BS, Shenoy RR. Epigenetic modulation of macrophage polarization- perspectives in diabetic wounds. J Diabetes Complications 2018; 32(5): 524-30.
[http://dx.doi.org/10.1016/j.jdiacomp.2018.01.015]
[18]
Drela E, Stankowska K, Kulwas A, Rość D. Endothelial progenitor cells in diabetic foot syndrome. Adv Clin Exp Med 2012; 21(2): 249-54.
[PMID: 23214290]
[19]
Seitz O, Schürmann C, Hermes N, et al. Wound healing in mice with high-fat diet- or ob gene-induced diabetes-obesity syndromes: A comparative study. Exp Diabetes Res 2010; 2010: 1-15.
[http://dx.doi.org/10.1155/2010/476969] [PMID: 21318183]
[20]
Balaji S, Han N, Moles C, et al. Angiopoietin-1 improves endothelial progenitor cell–dependent neovascularization in diabetic wounds. Surgery 2015; 158(3): 846-56.
[http://dx.doi.org/10.1016/j.surg.2015.06.034] [PMID: 26266763]
[21]
Schürmann C, Goren I, Linke A, Pfeilschifter J, Frank S. Deregulated unfolded protein response in chronic wounds of diabetic ob/ob mice: A potential connection to inflammatory and angiogenic disorders in diabetes-impaired wound healing. Biochem Biophys Res Commun 2014; 446(1): 195-200.
[http://dx.doi.org/10.1016/j.bbrc.2014.02.085] [PMID: 24583133]
[22]
Patel S, Srivastava S, Singh MR, Singh D. Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother 2019; 112: 108615.
[http://dx.doi.org/10.1016/j.biopha.2019.108615] [PMID: 30784919]
[23]
Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications 2006; 20(5): 329-35.
[http://dx.doi.org/10.1016/j.jdiacomp.2005.08.007] [PMID: 16949521]
[24]
Van Netten JJ, Woodburn J, Bus SA. The future for diabetic foot ulcer prevention: A paradigm shift from stratified healthcare towards personalized medicine. Diabetes Metab Res Rev 2020; 36(S1) (Suppl. 1): e3234.
[http://dx.doi.org/10.1002/dmrr.3234] [PMID: 31944530]
[25]
McGrath S, Ghersi D. Building towards precision medicine: Empowering medical professionals for the next revolution. BMC Med Genomics 2016; 9(1): 23.
[http://dx.doi.org/10.1186/s12920-016-0183-8] [PMID: 27160306]
[26]
Ashley EA. Towards precision medicine. Nat Rev Genet 2016; 17(9): 507-22.
[http://dx.doi.org/10.1038/nrg.2016.86] [PMID: 27528417]
[27]
Carr ALJ, Evans-Molina C, Oram RA. Precision medicine in type 1 diabetes. Diabetologia 2022; 65(11): 1854-66.
[http://dx.doi.org/10.1007/s00125-022-05778-3] [PMID: 35994083]
[28]
Chung WK, Erion K, Florez JC, et al. Precision medicine in diabetes: A consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020; 43(7): 1617-35.
[http://dx.doi.org/10.2337/dci20-0022] [PMID: 32561617]
[29]
Cook JC, Wu H, Aleo MD, Adkins K. Principles of precision medicine and its application in toxicology. J Toxicol Sci 2018; 43(10): 565-77.
[http://dx.doi.org/10.2131/jts.43.565] [PMID: 30298845]
[30]
Tranvåg EJ, Strand R, Ottersen T, Norheim OF. Precision medicine and the principle of equal treatment: A conjoint analysis. BMC Med Ethics 2021; 22(1): 55.
[http://dx.doi.org/10.1186/s12910-021-00625-3] [PMID: 33971875]
[31]
Naithani N, Sinha S, Misra P, Vasudevan B, Sahu R. Precision medicine: Concept and tools. Med J Armed Forces India 2021; 77(3): 249-57.
[http://dx.doi.org/10.1016/j.mjafi.2021.06.021] [PMID: 34305276]
[32]
Delpierre C, Lefèvre T. Precision and personalized medicine: What their current definition says and silences about the model of health they promote. Implication for the development of personalized health. Front Sociol 2023; 8: 1112159.
[http://dx.doi.org/10.3389/fsoc.2023.1112159] [PMID: 36895332]
[33]
Rich SS, Cefalu WT. The impact of precision medicine in diabetes: A multidimensional perspective. Diabetes Care 2016; 39(11): 1854-7.
[http://dx.doi.org/10.2337/dc16-1833] [PMID: 27926886]
[34]
Pearson E. Precision treatment in type 2 diabetes: Can we predict response and outcomes to diabetes therapies? PDM2021: A virtual conference. Day 3, workshop 1. 2021.
[35]
Flanagin A, Frey T, Christiansen SL. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA 2021; 326(7): 621-7.
[http://dx.doi.org/10.1001/jama.2021.13304] [PMID: 34402850]
[36]
Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018; 6(5): 361-9.
[http://dx.doi.org/10.1016/S2213-8587(18)30051-2] [PMID: 29503172]
[37]
Chambers DA, Feero WG, Khoury MJ. Convergence of implementation science, precision medicine, and the learning health care system: A new model for biomedical research. JAMA 2016; 315(18): 1941-2.
[http://dx.doi.org/10.1001/jama.2016.3867] [PMID: 27163980]
[38]
Klonoff DC. Precision medicine for managing diabetes. J Diabetes Sci Technol 2015; 9(1): 3-7.
[http://dx.doi.org/10.1177/1932296814563643] [PMID: 25550409]
[39]
Greeley SA, McCauley MK, Philipson LH, Sperling MA. Monogenic diabetes mellitus: Neonatal diabetes and maturity-onset diabetes of the young Sperling Pediatric Endocrinology. Amsterdam: Elsevier 2021.
[40]
Galiano RD, Tepper OM, Pelo CR, et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004; 164(6): 1935-47.
[http://dx.doi.org/10.1016/S0002-9440(10)63754-6] [PMID: 15161630]
[41]
Chen J, Li X, Liu H, et al. Bone marrow stromal cell‐derived exosomal circular RNA improves diabetic foot ulcer wound healing by activating the nuclear factor erythroid 2‐related factor 2 pathway and inhibiting ferroptosis. Diabet Med 2023; 40(7): e15031.
[http://dx.doi.org/10.1111/dme.15031] [PMID: 36537855]
[42]
Barrientos S, Brem H, Stojadinovic O, Tomic-Canic M. Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen 2014; 22(5): 569-78.
[http://dx.doi.org/10.1111/wrr.12205] [PMID: 24942811]
[43]
Han G, Ceilley R. Chronic wound healing: A review of current management and treatments. Adv Ther 2017; 34(3): 599-610.
[http://dx.doi.org/10.1007/s12325-017-0478-y] [PMID: 28108895]
[44]
You HJ, Han SK. Cell therapy for wound healing. J Korean Med Sci 2014; 29(3): 311-9.
[http://dx.doi.org/10.3346/jkms.2014.29.3.311] [PMID: 24616577]
[45]
Kolluru GK, Bir SC, Kevil CG. Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing. Int J Vasc Med 2012; 2019: 918267.
[http://dx.doi.org/10.1155/2012/918267]
[46]
Castilla DM, Liu ZJ, Tian R, Li Y, Livingstone AS, Velazquez OC. A novel autologous cell-based therapy to promote diabetic wound healing. Ann Surg 2012; 256(4): 560-72.
[http://dx.doi.org/10.1097/SLA.0b013e31826a9064] [PMID: 22964729]
[47]
Teng M, Huang Y, Zhang H. Application of stems cells in wound healing—An update. Wound Repair Regen 2014; 22(2): 151-60.
[http://dx.doi.org/10.1111/wrr.12152] [PMID: 24635168]
[48]
Jarajapu YPR, Grant MB. The promise of cell-based therapies for diabetic complications: Challenges and solutions. Circ Res 2010; 106(5): 854-69.
[http://dx.doi.org/10.1161/CIRCRESAHA.109.213140] [PMID: 20299675]
[49]
Huang Y, Kyriakides TR. The role of extracellular matrix in the pathophysiology of diabetic wounds. Matrix Biol Plus 2020; 6-7: 100037.
[http://dx.doi.org/10.1016/j.mbplus.2020.100037] [PMID: 33543031]
[50]
Kunkemoeller B, Kyriakides TR. Redox signaling in diabetic wound healing regulates extracellular matrix deposition. Antioxid Redox Signal 2017; 27(12): 823-38.
[http://dx.doi.org/10.1089/ars.2017.7263] [PMID: 28699352]
[51]
Torregrossa M, Kakpenova A, Simon JC, Franz S. Modulation of macrophage functions by ECM-inspired wound dressings – a promising therapeutic approach for chronic wounds. Biol Chem 2021; 402(11): 1289-307.
[http://dx.doi.org/10.1515/hsz-2021-0145] [PMID: 34390641]
[52]
Cho H, Blatchley MR, Duh EJ, Gerecht S. Acellular and cellular approaches to improve diabetic wound healing. Adv Drug Deliv Rev 2019; 146: 267-88.
[http://dx.doi.org/10.1016/j.addr.2018.07.019] [PMID: 30075168]
[53]
de Smet GHJ, Kroese LF, Menon AG, et al. Oxygen therapies and their effects on wound healing. Wound Repair Regen 2017; 25(4): 591-608.
[http://dx.doi.org/10.1111/wrr.12561] [PMID: 28783878]
[54]
Oropallo AR, Serena TE, Armstrong DG, Niederauer MQ. Molecular biomarkers of oxygen therapy in patients with diabetic foot ulcers. Biomolecules 2021; 11(7): 925.
[http://dx.doi.org/10.3390/biom11070925] [PMID: 34206433]
[55]
Hayes PD, Alzuhir N, Curran G, Loftus IM. Topical oxygen therapy promotes the healing of chronic diabetic foot ulcers: A pilot study. J Wound Care 2017; 26(11): 652-60.
[http://dx.doi.org/10.12968/jowc.2017.26.11.652] [PMID: 29131746]
[56]
Howard MA, Asmis R, Evans KK, Mustoe TA. Oxygen and wound care: A review of current therapeutic modalities and future direction. Wound Repair Regen 2013; 21(4): 503-11.
[http://dx.doi.org/10.1111/wrr.12069] [PMID: 23756299]
[57]
Lotfollahi Z, Dawson J, Fitridge R, Bursill C. The anti-inflammatory and proangiogenic properties of high-density lipoproteins: An emerging role in diabetic wound healing. Adv Wound Care (New Rochelle) 2021; 10(7): 370-80.
[http://dx.doi.org/10.1089/wound.2020.1308] [PMID: 33176621]
[58]
Shukla SK, Sharma AK, Gupta V, Yashavarddhan MH. Pharmacological control of inflammation in wound healing. J Tissue Viability 2019; 28(4): 218-22.
[http://dx.doi.org/10.1016/j.jtv.2019.09.002] [PMID: 31542301]
[59]
Salazar JJ, Ennis WJ, Koh TJ. Diabetes medications: Impact on inflammation and wound healing. J Diabetes Complications 2016; 30(4): 746-52.
[http://dx.doi.org/10.1016/j.jdiacomp.2015.12.017] [PMID: 26796432]
[60]
Yaghoobi R, Kazerouni A. kazerouni O. Evidence for clinical use of honey in wound healing as an anti-bacterial, anti-inflammatory anti-oxidant and anti-viral agent: A review. Jundishapur J Nat Pharm Prod 2013; 8(3): 100-4.
[http://dx.doi.org/10.17795/jjnpp-9487] [PMID: 24624197]
[61]
Monika P, Chandraprabha MN, Rangarajan A, Waiker PV, Chidambara Murthy KN. Challenges in healing wound: Role of complementary and alternative medicine. Front Nutr 2022; 8: 791899.
[http://dx.doi.org/10.3389/fnut.2021.791899] [PMID: 35127787]
[62]
Tavakoli S, Klar AS. Bioengineered skin substitutes: Advances and future trends. Appl Sci (Basel) 2021; 11(4): 1493.
[http://dx.doi.org/10.3390/app11041493]
[63]
Widgerow AD. Bioengineered skin substitute considerations in the diabetic foot ulcer. Ann Plast Surg 2014; 73(2): 239-44.
[http://dx.doi.org/10.1097/SAP.0b013e31826eac22] [PMID: 23511743]
[64]
Saap LJ, Donohue K, Falanga V. Clinical classification of bioengineered skin use and its correlation with healing of diabetic and venous ulcers. Dermatol Surg 2004; 30(8): 1095-100.
[PMID: 15274699]
[65]
Bhardwaj N, Chouhan D, Mandal BB. Tissue engineered skin and wound healing: Current strategies and future directions. Curr Pharm Des 2017; 23(24): 3455-82.
[PMID: 28552069]
[66]
Burgess JL, Wyant WA, Abdo Abujamra B, Kirsner RS, Jozic I. Diabetic wound-healing science. Medicina (Kaunas) 2021; 57(10): 1072.
[http://dx.doi.org/10.3390/medicina57101072] [PMID: 34684109]
[67]
Lebrun E, Tomic-Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen 2010; 18(5): 433-8.
[http://dx.doi.org/10.1111/j.1524-475X.2010.00619.x] [PMID: 20840517]
[68]
Demidova-Rice TN, Hamblin MR, Herman IM. Acute and impaired wound healing: Pathophysiology and current methods for drug delivery, part 2: Role of growth factors in normal and pathological wound healing: Therapeutic potential and methods of delivery. Adv Skin Wound Care 2012; 25(8): 349-70.
[http://dx.doi.org/10.1097/01.ASW.0000418541.31366.a3] [PMID: 22820962]
[69]
Hurlow JJ, Humphreys GJ, Bowling FL, McBain AJ. Diabetic foot infection: A critical complication. Int Wound J 2018; 15(5): 814-21.
[http://dx.doi.org/10.1111/iwj.12932] [PMID: 29808598]
[70]
Wang Z, Hasan R, Firwana B, et al. A systematic review and metaanalysis of tests to predict wound healing in diabetic foot. J Vasc Surg 2016; 63(2) (Suppl.): 29S-36S. 36S.e2.
[http://dx.doi.org/10.1016/j.jvs.2015.10.004] [PMID: 26804365]
[71]
Singh TP, Vangaveti VN, Kennedy RL, Malabu UH. Role of telehealth in diabetic foot ulcer management - A systematic review. Aust J Rural Health 2016; 24(4): 224-9.
[http://dx.doi.org/10.1111/ajr.12284] [PMID: 27098271]
[72]
Sood A, Granick MS, Trial C, et al. The role of telemedicine in wound care: A review and analysis of a database of 5,795 patients from a mobile wound-healing center in Languedoc-Roussillon, France. Plast Reconstr Surg 2016; 138(3S): 248S-56S.
[http://dx.doi.org/10.1097/PRS.0000000000002702] [PMID: 27556769]
[73]
Raghupathi W, Raghupathi V. Big data analytics in healthcare: Promise and potential. Health Inf Sci Syst 2014; 2(1): 3.
[http://dx.doi.org/10.1186/2047-2501-2-3] [PMID: 25825667]
[74]
Dankwa-Mullan I, Rivo M, Sepulveda M, Park Y, Snowdon J, Rhee K. Transforming diabetes care through artificial intelligence: The future is here. Popul Health Manag 2019; 22(3): 229-42.
[http://dx.doi.org/10.1089/pop.2018.0129] [PMID: 30256722]
[75]
Shankaracharya OD, Odedra D, Samanta S, Vidyarthi AS. Computational intelligence in early diabetes diagnosis: A review. Rev Diabet Stud 2010; 7(4): 252-62.
[http://dx.doi.org/10.1900/RDS.2010.7.252] [PMID: 21713313]
[76]
Ellahham S. Artificial intelligence: The future for diabetes care. Am J Med 2020; 133(8): 895-900.
[http://dx.doi.org/10.1016/j.amjmed.2020.03.033] [PMID: 32325045]
[77]
Zhao F, Chen Y, Hou Y, He X. Segmentation of blood vessels using rule-based and machine-learning-based methods: A review. Multimedia Syst 2019; 25(2): 109-18.
[http://dx.doi.org/10.1007/s00530-017-0580-7]
[78]
Anisuzzaman DM, Wang C, Rostami B, Gopalakrishnan S, Niezgoda J, Yu Z. Image-based artificial intelligence in wound assessment: A systematic review. Adv Wound Care (New Rochelle) 2022; 11(12): 687-709.
[http://dx.doi.org/10.1089/wound.2021.0091] [PMID: 34544270]
[79]
Zhavoronkov A, Vanhaelen Q, Oprea TI. Will artificial intelligence for drug discovery impact clinical pharmacology? Clin Pharmacol Ther 2020; 107(4): 780-5.
[http://dx.doi.org/10.1002/cpt.1795] [PMID: 31957003]
[80]
Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK. Artificial intelligence in drug discovery and development. Drug Discov Today 2021; 26(1): 80-93.
[http://dx.doi.org/10.1016/j.drudis.2020.10.010] [PMID: 33099022]
[81]
Jones GS, Baldwin DR. Recent advances in the management of lung cancer. Clin Med (Lond) 2018; 18(2) (Suppl. 2): s41-6.
[http://dx.doi.org/10.7861/clinmedicine.18-2-s41] [PMID: 29700092]
[82]
Paolillo S, Scardovi AB, Campodonico J. Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation. Eur J Prev Cardiol 2020; 27 (2_suppl)(Suppl.): 27-34.
[http://dx.doi.org/10.1177/2047487320960288] [PMID: 33238738]
[83]
Grinnell F, Billingham RE, Burgess L. Distribution of fibronectin during wound healing in vivo. J Invest Dermatol 1981; 76(3): 181-9.
[http://dx.doi.org/10.1111/1523-1747.ep12525694] [PMID: 7240787]
[84]
Repesh LA, Fitzgerald TJ, Furcht LT. Fibronectin involvement in granulation tissue and wound healing in rabbits. J Histochem Cytochem 1982; 30(4): 351-8.
[http://dx.doi.org/10.1177/30.4.6174568] [PMID: 6174568]
[85]
Gailit J, Clark RAF. Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 1994; 6(5): 717-25.
[http://dx.doi.org/10.1016/0955-0674(94)90099-X] [PMID: 7530463]
[86]
Gailit J, Clark RAF, Welch MP. TGF-β 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol 1994; 103(2): 221-7.
[http://dx.doi.org/10.1111/1523-1747.ep12393176] [PMID: 8040614]
[87]
Ongenae KC, Phillips TJ, Park HY. Level of fibronectin mRNA is markedly increased in human chronic wounds. Dermatol Surg 2000; 26(5): 447-51.
[http://dx.doi.org/10.1046/j.1524-4725.2000.99281.x] [PMID: 10816233]
[88]
Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45(7): 1011-6.
[http://dx.doi.org/10.1007/s00125-002-0868-8] [PMID: 12136400]
[89]
Lobmann R, Schultz G, Lehnert H. [Molecular fundamentals of wound healing in diabetic foot syndrome]. Med Klin (Munich) 2003; 98(5): 292-301.
[http://dx.doi.org/10.1007/s00063-003-1260-2] [PMID: 12721676]
[90]
Nwomeh BC, Liang HX, Cohen IK, Yager DR. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 1999; 81(2): 189-95.
[http://dx.doi.org/10.1006/jsre.1998.5495] [PMID: 9927539]
[91]
Barone EJ, Yager DR, Pozez AL, et al. Interleukin-1alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg 1998; 102(4): 1023-7.
[http://dx.doi.org/10.1097/00006534-199809020-00015] [PMID: 9734419]
[92]
Dinh TL, Veves A. A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds 2005; 4(3): 154-9.
[http://dx.doi.org/10.1177/1534734605280130] [PMID: 16100096]
[93]
Holzer P. Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 1998; 30(1): 5-11.
[http://dx.doi.org/10.1016/S0306-3623(97)00078-5] [PMID: 9457475]
[94]
Forst T, Pfützner A, Kunt T, et al. Skin microcirculation in patients with type I diabetes with and without neuropathy after neurovascular stimulation. Clin Sci (Lond) 1998; 94(3): 255-61.
[http://dx.doi.org/10.1042/cs0940255] [PMID: 9616259]
[95]
Nakagawa N, Sano H, Iwamoto I. Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration. Peptides 1995; 16(4): 721-5.
[http://dx.doi.org/10.1016/0196-9781(95)00037-K] [PMID: 7479308]
[96]
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3(5): 349-63.
[http://dx.doi.org/10.1038/nrm809] [PMID: 11988769]
[97]
Carver W, Nagpal ML, Nachtigal M, Borg TK, Terracio L. Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res 1991; 69(1): 116-22.
[http://dx.doi.org/10.1161/01.RES.69.1.116] [PMID: 2054929]
[98]
Rohr S. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc Res 2004; 62(2): 309-22.
[http://dx.doi.org/10.1016/j.cardiores.2003.11.035] [PMID: 15094351]
[99]
Camelliti P, Borg T, Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 2005; 65(1): 40-51.
[http://dx.doi.org/10.1016/j.cardiores.2004.08.020] [PMID: 15621032]
[100]
Goldsmith EC, Hoffman A, Morales MO, et al. Organization of fibroblasts in the heart. Dev Dyn 2004; 230(4): 787-94.
[http://dx.doi.org/10.1002/dvdy.20095] [PMID: 15254913]
[101]
Qiu C, Coutinho P, Frank S, et al. Targeting connexin43 expression accelerates the rate of wound repair. Curr Biol 2003; 13(19): 1697-703.
[http://dx.doi.org/10.1016/j.cub.2003.09.007] [PMID: 14521835]
[102]
Saitoh M, Oyamada M, Oyamada Y, Kaku T, Mori M. Changes in the expression of gap junction proteins (connexins) in hamster tongue epithelium during wound healing and carcinogenesis. Carcinogenesis 1997; 18(7): 1319-28.
[http://dx.doi.org/10.1093/carcin/18.7.1319] [PMID: 9230274]
[103]
Coutinho P, Qiu C, Frank S, Tamber K, Becker D. Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol Int 2003; 27(7): 525-41.
[http://dx.doi.org/10.1016/S1065-6995(03)00077-5] [PMID: 12842092]
[104]
Mansbridge J. Skin substitutes to enhance wound healing. Expert Opin Investig Drugs 1998; 7(5): 803-9.
[http://dx.doi.org/10.1517/13543784.7.5.803] [PMID: 15991970]
[105]
Mansbridge J, Liu K, Patch R, Symons K, Pinney E. Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: Metabolic activity and therapeutic range. Tissue Eng 1998; 4(4): 403-14.
[http://dx.doi.org/10.1089/ten.1998.4.403] [PMID: 9916172]

Rights & Permissions Print Cite
Article Metrics
Pdf icon 32
Html icon 3
Find your institution